Accessibility: Skip TopNav
Thomas K. Equels, President & CEO, Hemispherx Biopharma, Inc.
Thomas K. Equels, President & CEO, Hemispherx Biopharma, Inc.
Format
JPEG
Quelle:
AIM ImmunoTech Inc.
Downloads
Originalgröße
Groß
Mittel
Klein